echemi logo
Product
  • Product
  • Supplier
  • Inquiry
    Home > Medical News > Medical Science News > The durability and cross-protection law of neutralizing antibodies for COVID-19 patients revealed

    The durability and cross-protection law of neutralizing antibodies for COVID-19 patients revealed

    • Last Update: 2021-12-02
    • Source: Internet
    • Author: User
    Search more information of high quality chemicals, good prices and reliable suppliers, visit www.echemi.com


    The reporter learned from Wuhan University that recently, the State Key Laboratory of Virology of Wuhan University and the Hubei Provincial Center for Disease Control and Prevention have made new progress in the research on the persistence and cross-protective activity of neutralizing antibodies in patients recovering from the new coronavirus.


    According to reports, the researchers collected 248 serum samples from patients infected with the new crown virus in Wuhan after recovering one year, and conducted a series of studies


    The study also found that the neutralizing antibodies in the serum of most recovered patients can effectively neutralize the wild and British strains of the new coronavirus (B.


    Researchers said that this result suggests that there may be a broad-spectrum SARS-CoV-2 neutralizing epitope, which brings hope for the development of broad-spectrum neutralizing antibodies and a broad-spectrum new crown vaccine


    The receptor binding domain (RBD) is a key region for virus-mediated invasion.


    In summary, the study provides reliable evidence that the new coronavirus-specific neutralizing antibodies in most recovered patients in Wuhan can last for at least one year, and can effectively neutralize wild and British strains, but for some mutations Strains, especially South African strains and Indian strains, showed a significant decrease in their antibody neutralization ability


    Based on the research results, the researchers further proposed to update the S protein amino acid sequence of the vaccine in a timely manner, rationally arrange the time for boosting immunization, or a more economical, feasible and scientific immunization strategy


    The research results were recently published in "Innovation"


    Related paper information: https://doi.


    https://doi.
    org/10.
    1016/j.
    xinn.
    2021.
    100181
    This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only. This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed description of the concern or complaint, to service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content will be removed immediately.

    Contact Us

    The source of this page with content of products and services is from Internet, which doesn't represent ECHEMI's opinion. If you have any queries, please write to service@echemi.com. It will be replied within 5 days.

    Moreover, if you find any instances of plagiarism from the page, please send email to service@echemi.com with relevant evidence.